Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
PHARMCO II ApS
APS
Active
CVR 25202899
Tinglykke 4-6, 6500
Vojens
Activities of holding companies
·
NACE 6421
Est. 2000 · 26 years old
— employees
Overvåg
Share
Denmark
/
Companies
/
Activities of holding companies
/
PHARMCO II ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Gross profit
0
0
-47
-50
-56
Staff expenses
-0
-0
-0
-0
-0
EBITDA
0
0
-47
-50
-56
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
0
0
-47
-50
-56
Net financials
4.763
-1.726
14.330
7.888
42.070
Profit before tax
4.763
-1.726
14.283
7.838
42.014
Tax
592
-1
1.313
741
7.582
Net profit
4.172
-1.724
12.970
7.097
34.432
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
73.860
95.369
109.403
119.598
126.817
Equity
73.823
72.096
85.089
92.124
107.079
Long-term debt
0
0
0
0
0
Short-term debt
37
23.272
24.314
27.474
19.738
Total debt
37
23.272
24.314
27.474
19.738
Financial ratios
5-year trend
EBITDA-margin (af bruttofortjeneste)
-5600000.0%
This company
2021
2025
Soliditetsgrad
84.4%
This company
38.2%
Market median
+121% vs market
2021
2025
Egenkapitalforrentning
32.2%
This company
18.4%
Market median
+75% vs market
2021
2025
Nettoresultatgrad (af bruttofortjeneste)
3443200000.0%
This company
2021
2025
Aktivomsætning (af bruttofortjeneste)
-0.00×
This company
2021
2025
Gæld/egenkapital
0.18×
This company
0.62×
Market median
+71% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
More on PHARMCO II ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
